Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cubist Systematic Strategies is a quantitative investment firm and the systematic investing business of Point72. It specializes in designing and implementing systematic, computer-driven trading strategies across multiple liquid asset classes such as equities, futures, and foreign exchange. The firm emphasizes rigorous research into market anomalies using advanced technology and data-driven decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cubist Systematic Strategies.